- Home
- FLUX vs CLNN Comparison
FLUX vs CLNN Comparison
Compare FLUX & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- CLNN
- Stock Information
- Founded
- FLUX N/A
- CLNN 2012
- Country
- FLUX United States
- CLNN United States
- Employees
- FLUX N/A
- CLNN N/A
- Industry
- FLUX Industrial Machinery/Components
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- FLUX Miscellaneous
- CLNN Health Care
- Exchange
- FLUX Nasdaq
- CLNN Nasdaq
- Market Cap
- FLUX 25.4M
- CLNN 23.1M
- IPO Year
- FLUX N/A
- CLNN N/A
- Fundamental
- Price
- FLUX $1.83
- CLNN $3.65
- Analyst Decision
- FLUX Strong Buy
- CLNN Strong Buy
- Analyst Count
- FLUX 2
- CLNN 5
- Target Price
- FLUX $6.00
- CLNN $40.00
- AVG Volume (30 Days)
- FLUX 154.8K
- CLNN 52.3K
- Earning Date
- FLUX 08-15-2025
- CLNN 08-06-2025
- Dividend Yield
- FLUX N/A
- CLNN N/A
- EPS Growth
- FLUX N/A
- CLNN N/A
- EPS
- FLUX N/A
- CLNN N/A
- Revenue
- FLUX $63,074,000.00
- CLNN $350,000.00
- Revenue This Year
- FLUX $11.10
- CLNN N/A
- Revenue Next Year
- FLUX $12.66
- CLNN $1,753.57
- P/E Ratio
- FLUX N/A
- CLNN N/A
- Revenue Growth
- FLUX N/A
- CLNN N/A
- 52 Week Low
- FLUX $1.15
- CLNN $2.28
- 52 Week High
- FLUX $3.99
- CLNN $6.96
- Technical
- Relative Strength Index (RSI)
- FLUX 48.43
- CLNN 44.42
- Support Level
- FLUX $1.88
- CLNN $3.60
- Resistance Level
- FLUX $2.15
- CLNN $3.99
- Average True Range (ATR)
- FLUX 0.22
- CLNN 0.21
- MACD
- FLUX -0.02
- CLNN -0.03
- Stochastic Oscillator
- FLUX 16.25
- CLNN 25.53
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.